GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,509,000 | -5.7% | 39,502 | -0.6% | 1.44% | +15.1% |
Q2 2018 | $1,601,000 | -2.6% | 39,727 | -5.6% | 1.25% | -5.6% |
Q1 2018 | $1,644,000 | +9.7% | 42,077 | -0.4% | 1.33% | +9.0% |
Q4 2017 | $1,498,000 | -12.6% | 42,229 | 0.0% | 1.22% | -12.1% |
Q3 2017 | $1,714,000 | -6.5% | 42,229 | -0.7% | 1.39% | -12.1% |
Q2 2017 | $1,834,000 | +2.3% | 42,529 | 0.0% | 1.58% | +13.4% |
Q1 2017 | $1,793,000 | +9.5% | 42,529 | 0.0% | 1.39% | +5.7% |
Q4 2016 | $1,638,000 | -10.7% | 42,529 | 0.0% | 1.32% | -10.8% |
Q3 2016 | $1,834,000 | +6.3% | 42,529 | +6.9% | 1.48% | +4.3% |
Q2 2016 | $1,725,000 | +7.4% | 39,800 | +0.5% | 1.41% | +1.5% |
Q1 2016 | $1,606,000 | +0.5% | 39,600 | 0.0% | 1.39% | -1.1% |
Q4 2015 | $1,598,000 | +2.2% | 39,600 | -2.6% | 1.41% | -4.0% |
Q3 2015 | $1,563,000 | -6.2% | 40,656 | +1.6% | 1.47% | +5.0% |
Q2 2015 | $1,667,000 | -10.0% | 40,031 | -0.2% | 1.40% | -11.9% |
Q1 2015 | $1,852,000 | +6.9% | 40,131 | -1.0% | 1.58% | +6.0% |
Q4 2014 | $1,732,000 | – | 40,531 | – | 1.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $17,248,000 | 7.33% |
KAHN BROTHERS GROUP INC | 1,055,085 | $45,495,265,000 | 6.94% |
NEXTHERA CAPITAL LP | 322,000 | $13,885,000 | 6.05% |
EQUITY INVESTMENT CORP | 2,494,668 | $107,570,000 | 3.68% |
Bruderman Asset Management, LLC | 310,248 | $13,378,000 | 3.57% |
Keystone Financial Planning, Inc. | 131,006 | $5,649,000 | 3.42% |
SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $19,404,000 | 3.30% |
Hamlin Capital Management, LLC | 1,765,115 | $76,112,000 | 3.18% |
Holloway Wealth Management, LLC | 116,899 | $5,041,000 | 3.16% |
P.R. Herzig & Co. Inc. | 37,650 | $1,623,000 | 3.14% |